These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 17118432

  • 1. Monitoring Unfractionated Heparin (UFH) therapy: which Anti-Factor Xa assay is appropriate?
    Ignjatovic V, Summerhayes R, Gan A, Than J, Chan A, Cochrane A, Bennett M, Horton S, Shann F, Lane G, Ross-Smith M, Monagle P.
    Thromb Res; 2007; 120(3):347-51. PubMed ID: 17118432
    [Abstract] [Full Text] [Related]

  • 2. Clinical use of unfractionated heparin therapy in children: time for change?
    Newall F, Ignjatovic V, Johnston L, Summerhayes R, Lane G, Cranswick N, Monagle P.
    Br J Haematol; 2010 Sep; 150(6):674-8. PubMed ID: 20629660
    [Abstract] [Full Text] [Related]

  • 3. Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay.
    Kitchen S, Theaker J, Preston FE.
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):137-44. PubMed ID: 10759006
    [Abstract] [Full Text] [Related]

  • 4. In vivo age dependency of unfractionated heparin in infants and children.
    Newall F, Ignjatovic V, Summerhayes R, Gan A, Butt W, Johnston L, Monagle P.
    Thromb Res; 2009 Mar; 123(5):710-4. PubMed ID: 18829072
    [Abstract] [Full Text] [Related]

  • 5. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
    Atkinson HM, Mewhort-Buist TA, Berry LR, Chan AK.
    Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
    [Abstract] [Full Text] [Related]

  • 6. Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin.
    Newall F, Ignjatovic V, Johnston L, Summerhayes R, Lane G, Cranswick N, Monagle P.
    Thromb Haemost; 2010 May; 103(5):1085-90. PubMed ID: 20174762
    [Abstract] [Full Text] [Related]

  • 7. A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring.
    Vandiver JW, Vondracek TG.
    Hosp Pract (1995); 2013 Apr; 41(2):16-24. PubMed ID: 23545756
    [Abstract] [Full Text] [Related]

  • 8. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ, Rosenberg AF, Winterstein AG, Harris NS, Johns TE, Zumberg MS.
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [Abstract] [Full Text] [Related]

  • 9. Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy.
    Clark NP, Delate T, Cleary SJ, Witt DM.
    Thromb Res; 2010 May; 125(5):402-5. PubMed ID: 19699510
    [Abstract] [Full Text] [Related]

  • 10. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R.
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [Abstract] [Full Text] [Related]

  • 11. Comparison of low molecular weight heparins and unfractionated heparin after successive subcutaneous administration. A randomized controlled study in healthy volunteers.
    Pindur G, Heiden M, Köhler M.
    Arzneimittelforschung; 1993 May; 43(5):542-7. PubMed ID: 8392345
    [Abstract] [Full Text] [Related]

  • 12. Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and low-molecular-weight heparins, fondaparinux, and thrombin inhibitors.
    Calatzis A, Peetz D, Haas S, Spannagl M, Rudin K, Wilmer M.
    Am J Clin Pathol; 2008 Sep; 130(3):446-54. PubMed ID: 18701419
    [Abstract] [Full Text] [Related]

  • 13. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V, Béguin S, Boneu B, Hemker HC.
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [Abstract] [Full Text] [Related]

  • 14. Anti-factor Xa (anti-Xa) assay.
    Newall F.
    Methods Mol Biol; 2013 Feb; 992():265-72. PubMed ID: 23546719
    [Abstract] [Full Text] [Related]

  • 15. The effect of calcium chloride on anti-Xa activity of heparin and its molecular weight fractions.
    Barrowcliffe TW, Le Shirley Y.
    Thromb Haemost; 1989 Nov 24; 62(3):950-4. PubMed ID: 2556814
    [Abstract] [Full Text] [Related]

  • 16. Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis.
    Potze W, Arshad F, Adelmeijer J, Blokzijl H, van den Berg AP, Porte RJ, Lisman T.
    Br J Haematol; 2013 Dec 24; 163(5):666-73. PubMed ID: 24219333
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low-molecular weight heparin.
    Ip BK, Thomson AR, Moriarty HT.
    Pathology; 2001 Aug 24; 33(3):347-52. PubMed ID: 11523938
    [Abstract] [Full Text] [Related]

  • 18. The correlation between plasma anti-factor Xa activity and haemostatic tests in healthy dogs, following the administration of a low molecular weight heparin.
    Mischke R, Grebe S.
    Res Vet Sci; 2000 Dec 24; 69(3):241-7. PubMed ID: 11124095
    [Abstract] [Full Text] [Related]

  • 19. Low molecular weight heparin in haemodialysis for chronic renal failure: dose finding study of CY222.
    Ireland H, Lane DA, Flynn A, Pegrum AC, Curtis JR.
    Thromb Haemost; 1988 Apr 08; 59(2):240-7. PubMed ID: 2838924
    [Abstract] [Full Text] [Related]

  • 20. Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability.
    Kitchen S, Iampietro R, Woolley AM, Preston FE.
    Thromb Haemost; 1999 Oct 08; 82(4):1289-93. PubMed ID: 10544915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.